Table 1.
Acute stress | Skin function affected | Main biological mechanisms | Clinical manifestations |
---|---|---|---|
Solar radiation | Barrier | TEWL | Dryness |
Pigmentation | Melanogenesis | PIHP, tanning, melasma exacerbation, dark spots | |
Defences | Oxidative stress, 31 DNA damage, inflammation, 19 decrease in epidermal Langerhans cells, 35 Treg expansion, 36 , 37 microbiome alteration, 21 photoimmunosuppression 19 | Sunburn, photosensitivity, photoallergy, actinic keratoses, viral reactivation, herpes labialis. Improvement of some dermatoses (psoriasis, atopic dermatitis), Koebner phenomenon, photodermatoses (e.g. polymorphous light eruption) | |
Neuroendocrinology |
Neurogenic inflammation, 44 , 45 upregulation of CRH, 46 , 47 vitamin D synthesis, opioid release, 42 decreased blood pressure 39 |
Pruritus, hypersensitivity, atopic dermatitis, rosacea | |
Thermoregulation function and systemic effect | Vasodilatation 49 , 50 | Fever, erythema, rosacea flushes | |
Skin structure | Hyaluronic acid degradation from epidermis and dermis extracellular matrix degradation via oxidative stress | Dryness, wrinkles, skin laxity | |
Pollution | Barrier |
Change in sebum, squalene peroxidation 58 |
Dryness, skin sensitivity Flares of acne, atopic dermatitis |
Pigmentation | Pigmentation 57 | Dark spots | |
Defences | Oxidative stress, 60 , 61 microbiome alteration, 65 pro‐inflammatory immune response | Flares of acne, atopic dermatitis | |
Neuroendocrinology | Neurotrophic factor artemin 69 | Pruritus, flares of atopic dermatitis | |
Pollution and ultraviolet radiation | Defences | Oxidative stress 74 , pigmentation, oxinflammation 64 |
Photoaging, dark spots and wrinkles |
Meteorological changes | Barrier | TEWL, 75 , 78 sebum production | Dryness, oily skin and scalp, pruritus, flares/improvement of atopic dermatitis, psoriasis |
Structure | Hypersudation | Sweat | |
Defences | Inflammation 67 | Skin sensitivity, flares of atopic dermatitis, rosacea | |
Psychosocial stress | Barrier | TEWL, tight junction dysfunction | Dryness, transgression of microbes, toxins, allergens |
Structure | Piloerection, sweating, hair loss by anagen termination and telogen effluvium, alopecia | ||
Defences | Oxidative stress, inflammation 102 , immune suppression | Flares of acne, rosacea, psoriasis, alopecia areata, vitiligo, seborrhoeic dermatitis, atopic dermatitis, skin superinfection, viral reactivation | |
Neuroendocrinology | Neurogenic inflammation, hyper‐innervation, 87 , 88 , 90 upregulation of CRH 94 , 95 , 96 | Erythema, oedema, pruritus, pain | |
Thermoregulation | Vasodilation, vasoconstriction | Pale skin, hypothermia, redness | |
Sleep deprivation | Barrier | TEWL 7 | Dryness, dullness |
Defences | Oxidative stress, 111 inflammation 107 | Pruritus, flares of psoriasis, atopic dermatitis, seborrhoeic dermatitis, acne, skin superinfection, viral reactivation | |
Nutrition | Barrier | Lipid/ sebum production 121 , 124 | Dry skin, oily skin |
Defences | Antioxidant, inflammation, 123 allergic reactions, 130 microbiome 122 | Acne, atopic dermatitis, systemic contact dermatitis | |
Neuroendocrinology | Flushing, rosacea exacerbations | ||
Hormonal variations | Skin barrier | Oily skin, dry skin | |
Structure | Hypersudation | Telogen effluvium, androgenic alopecia | |
Defences | Oxidative stress, melatonin (antioxidant), oxytocin 140 , inflammation 136 , 138 | Acne, atopic dermatitis, aphtous ulcers | |
Neuroendocrinology | Stimulation of the HPA, 142 , 143 GC, 144 modulation of skin neuropeptides 145 | Progesterone dermatitis | |
Medications and procedures | Skin barrier | Irritation, dryness and erythema | |
Defences | Inflammation, antimicrobial response, 152 , 153 changes in microbiome | Acne, superinfection, viral reactivation | |
Mask use, disinfectants, frequent washing | Barrier and defence | Skin temperature, sebum, TEWL 158 | Dryness, pruritus, skin sensitivity, erythema, acne and rosacea flares |
CA, cholinergic axis; CRH, corticotrophin‐releasing hormone; HPA, hypothalamus–pituitary–adrenal axis; PIHP, postinflammatory hyperpigmentation; TEWL, trans‐epidermal water loss;